neotiv GmbH

neotiv GmbH is a German digital health company founded in 2017, headquartered in Magdeburg and originating from Otto von Guericke University and the German Centre for Neurodegenerative Diseases. The company develops a sophisticated digital platform delivering proprietary cognitive assessments for early detection and longitudinal monitoring of neurodegenerative diseases, particularly Alzheimer's disease. neotiv's platform combines neuroscience research with mobile software (smartphones and tablets) to provide user-friendly, remote cognitive testing capabilities. The core product suite includes neotivCare—a healthcare-certified solution for clinical cognitive impairment monitoring—and a customizable cognitive assessment battery that tracks Alzheimer's-specific cognitive signatures through validated neuropsychological tests and health questionnaires. The platform features neotivTrials, a web portal enabling researchers and physicians to design individualized study configurations with direct app deployment for mobile or on-site assessments. Applications span clinical research, drug development support, diagnostic support, and patient monitoring in hospital and research settings. The platform is validated for medical use and integrated into clinical workflows globally.